Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1997Human Gene Therapy

Immune Responses to Reporter Proteins and High Viral Dose Limit Duration of Expression with Adenoviral Vectors: Comparison of E2a Wild Type and E2a Deleted Vectors

View Full Paper
Ask AI
Bookmark
Share

Authors

NMNúria MorralIndiana University – Purdue University IndianapolisWOWanda K. O’NealUniversity of North Carolina at Chapel HillHZHeshan ZhouHangzhou First People's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morral et al. (1997) studied this question.

synapsesocial.com/papers/6a9d80e030bdd6b10046e64bhttps://doi.org/10.1089/hum.1997.8.10-1275
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis.1994 · 126 citations
  2. 2Intraperitoneal In Vivo Gene Therapy to Deliver α1-Antitrypsin to the Systemic Circulation1994 · 102 citations
  3. 3Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs1996 · 263 citations
  4. 4Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.1995 · 596 citations
  5. 5Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses1995 · 1,036 citations